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Background:  A clear association between a putative single nucleotide polymorphism (9p21) (rs10757274) in chromosome 9 and risk of coronary 
heart disease (CHD) has been established but the mechanism of increased risk is still unclear. Small studies in older adults indicate that aortic 
distensibility and compliance may be associated with 9p21. We examined the association between 9p21 and six arterial stiffness parameters 
obtained by carotid ultrasound. These variables were also tested as possible confounders in relationship between 9p21 and incident CHD among 
7745 white ARIC participants.
Methods:  9p21 was defined as a dichotomous variable (1 or 2 risk alleles versus 0). Differences in arterial stiffness measures (continuous 
variables) between those with and without the 9p21 risk allele were examined using t-tests from linear regression models (table). Hazard ratios 
(95%CI) were calculated to examine if the arterial stiffness measures changed the association between 9p21 and incident CHD
Results:  There were no differences in any of the arterial stiffness parameters between those with and without the risk allele (P>0.1 for all) (table). 
As expected, the association between 9p21 and incident CHD remained unchanged [HR 1.2; 95% CI 1.1, 1.3] when the arterial stiffness parameters 
were included.
Conclusion: No significant associations between 9p21 and parameters of arterial stiffness were noted suggesting that arterial stiffness is unlikely 
to explain the association between 9p21 and CHD. 
Associations between 9p21 allele status and arterial stiffness, measured using six parameters*
t-Test P value
Arterial Strain 0.62 0.53
Compliance 0.22 0.82
Distensibility 0.28 0.78
Stiffness Index 0.38 0.71
Pressure Strain Modulus (Ep) 0.37 0.71
Young’s elastic modulus 0.18 0.86
*Adjusted for age, gender, systolic blood pressure, anti-hypertensive medication use, smoking, total cholesterol, HDL-cholesterol and diabetes
Arterial strain (CAS)= (DS - DD) / DD,
compliance = pi * (DS2 - DD2) / (4 * PP)
distensibility = 100 * (DS2 - DD2) / (PP * DD2)
stiffness index = log (SBP / DBP) / CAS
Pressure strain modulus = PP / CAS
Young’s Elastic Modulus = (0.5 * DD / CIMT) * Ep
DS = peak systolic arterial diameter
DD = end diastolic arterial diameter
SBP = systolic blood pressure
DBP = diastolic blood pressure
PP = pulse pressure
